
Pulmonary fibrosis - Symptoms and causes - Mayo Clinic
Feb 15, 2024 · Pulmonary fibrosis with no known cause is called idiopathic pulmonary fibrosis. Many people with idiopathic pulmonary fibrosis also may have gastroesophageal reflux disease, also called GERD. This condition occurs when acid …
Pulmonary fibrosis - Diagnosis and treatment - Mayo Clinic
Feb 15, 2024 · Pulmonary fibrosis is a life-long lung condition that worsens over time. Having pulmonary fibrosis can cause fear, depression and stress. Here are some tips that may help you cope. Learn about your condition. Understanding the condition and treatments can help you and your family cope. Spend time with family and friends.
Updates in interstitial lung disease: Current facets of anti-fibrotic ...
Oct 18, 2019 · Teng Moua, M.D., discusses recent clinical trials and current research into the treatment of idiopathic pulmonary fibrosis (IPF) and non-IPF-progressive interstitial lung diseases.
Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns …
Sep 12, 2018 · Pirfenidone and nintedanib are approved for treatment of idiopathic pulmonary fibrosis (IPF), but questions remain regarding indications and timing of initiation, side effects, and long-term outcomes.
Pulmonary fibrosis care at Mayo Clinic
Feb 15, 2024 · Doctors at Mayo Clinic do research and use novel therapies to treat pulmonary fibrosis and related conditions. Mayo Clinic offers the latest medicines to treat idiopathic pulmonary fibrosis, which may help slow the condition over time.
AI enables early identification, intervention in debilitating lung …
Oct 4, 2022 · In a new study published in Nature Medicine, Mayo Clinic and several research collaborators from across the U.S., describe a successful new artificial intelligence, or AI, -enabled tool to identify idiopathic pulmonary fibrosis, also called IPF, before patients have recognizable symptoms. This tool could alert a patient's primary care team of a ...
Science Saturday: AI enables early identification, intervention in ...
Oct 29, 2022 · In a new study published in Nature Medicine, Mayo Clinic and several research collaborators from across the U.S., describe a successful new artificial intelligence, or AI, -enabled tool to identify idiopathic pulmonary fibrosis, also called IPF, before patients have recognizable symptoms. This tool could alert a patient's primary care team of a ...
Shortened telomeres heighten risk of serious lung disease
Dec 16, 2023 · Some patients with pulmonary fibrosis have shortened telomeres, the caps on the ends of chromosomes that protect cells from aging. Identifying these patients is critical because, in their case, certain treatments like immunosuppressive therapies could be dangerous.
Pulmonary fibrosis - Doctors and departments - Mayo Clinic
Feb 15, 2024 · Mayo Clinic pulmonary scientists study pulmonary fibrosis and other lung diseases and do clinical trials. Mayo researchers study the causes, diagnostic tests and possible treatments for pulmonary fibrosis and other lung diseases. You may have the …
Interstitial lung disease - Symptoms and causes - Mayo Clinic
Nov 23, 2024 · IPF is a typically progressive lung disease that occurs when lung tissue becomes damaged and scarred — what's known as fibrosis. Idiopathic means the cause isn't known. IPF can be seen on imaging and biopsy if a lung biopsy is taken.